{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"4.160","rs_stock_flag":false,"fiscal_year_end":"2024年12月31日","hist_closedate":"2025年9月25日","replication_method":null,"amt_os":"507,673,711","primaryexch":"香港交易所","ric":"6660.HK","product_subtype":null,"db_updatetime":"2025年9月28日08:06","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":0.0,"inline_upper_strike_price":"","sedol":"BQ0QV84","am":"9.85","iv":"","ew_strike":"","as":"3.990","geographic_focus":null,"incorpin":"中華人民共和國","etp_baseCur":null,"ew_amt_os":"","bd":"3.980","registrar":"卓佳證券登記有限公司","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"200","update_time":"2025-09-28 00:06:03.0","lo52":"3.030","shares_issued_date":"2025年8月31日","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"周延","underlying_ric":"6660.HK","hi52":"15.480","issuer_name":"艾美疫苗股份有限公司 - H股","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"2025年9月26日16:08","aum_date":"","lo":"3.920","mkt_cap":"2.02","f_aum_hkd":null,"ew_sub_per_to":"","ls":"3.990","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"醫療保健業 - 藥品及生物科技","ew_desc":null,"inception_date":"","nc":"-0.150","aum":"","issued_shares_class_B":null,"vo":"2.45","secondary_listing_flag":false,"listing_date":"2022年10月6日","issued_shares_class_A":null,"as_at_label":"截至","ew_amt_os_dat":"","nm":"艾美疫苗股份有限公司 - H股","nm_s":"艾美疫苗","sym":"6660","inline_lower_strike_price":"","listing_category":"主要上市","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.010","strike_price":"","summary":"艾美疫苗股份有限公司是一家主要從事疫苗研發、製造和銷售的中國公司。該公司已商業化產品主要包括重組乙型肝炎疫苗、凍干人用狂犬病疫苗、甲型肝炎滅活疫苗、腮腺炎疫苗、雙價腎綜合徵出血熱滅活疫苗以及A、C、Y及W135群腦膜炎球菌多糖疫苗。該公司的在研疫苗產品包括13價肺炎結合疫苗、24價肺炎結合疫苗、四價MDCK細胞流感病毒疫苗、無血清迭代狂犬病疫苗、mRNA带状疱疹疫苗、mRNA迭代狂犬病疫苗、mRNA呼吸道合胞病毒RSV疫苗、新型工藝高效價人二倍體狂犬病疫苗等。","op":"4.150","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"藥品","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"中國北京市大興區<br/>瀛海鎮鎮區瀛順路16號<br/>興海大廈<br/>2層218室","pc":"-3.62","days_to_expiry":null,"underlying_code":null,"pe":"","eps_ccy":"RMB","hdr":false,"launch_date":"","hc":"4.140","isin":"CNE100005KF2","moneyness":""}},"qid":"1759074382853"}
